XUCS:LSE:LSE-Xtrackers MSCI USA Consumer Staples UCITS (USD)

ETF | Others |

Last Closing

USD 47.51

Change

0.00 (0.00)%

Market Cap

USD 0.35B

Volume

10.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-11 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-1.50 (-0.70%)

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.15 (-1.01%)

USD 640.06B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.15 (-0.78%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

+4.28 (+3.29%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
PRJU:LSE Amundi Index Solutions - Amund..

-0.26 (-0.83%)

USD 269.13B
0QZK:LSE Coca-Cola Co.

-0.10 (-0.14%)

USD 266.08B
0QZO:LSE 0QZO

+0.80 (+0.72%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

+0.70 (+0.46%)

USD 202.26B
0R24:LSE Intel Corp.

-1.06 (-4.66%)

USD 196.14B

ETFs Containing XUCS:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.53% 74% C 68% D+
Dividend Return 1.03% 65% D 69% C-
Total Return 5.56% 76% C+ 70% C-
Trailing 12 Months  
Capital Gain 8.09% 75% C 71% C-
Dividend Return 2.11% 60% D- 67% D+
Total Return 10.20% 81% B- 75% C
Trailing 5 Years  
Capital Gain 45.14% 49% F 58% F
Dividend Return 16.70% 75% C 87% B+
Total Return 61.83% 55% F 64% D
Average Annual (5 Year Horizon)  
Capital Gain 6.93% 55% F 60% D-
Dividend Return 7.94% 58% F 63% D
Total Return 1.02% 64% D 84% B
Risk Return Profile  
Volatility (Standard Deviation) 7.81% 72% C 85% B
Risk Adjusted Return 101.75% 89% A- 94% A
Market Capitalization 0.35B 67% D+ 39% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike